LuHui Derivative, A Novel Compound That Inhibits the Fat Mass and Obesity-Associated (FTO), Alleviates the Inflammatory Response and Injury in Hyperlipidemia-Induced Cardiomyopathy

Hyperlipidemia is a major risk factor for metabolic disorders and cardiovascular injury. The excessive deposition of saturated fatty acids in the heart leads to chronic cardiac inflammation, which in turn causes myocardial damage and systolic dysfunction. However, the effective suppression of cardia...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ying, Pan, Yumiao, Fan, Ziyi, Xu, Silun, Gao, Zhiyuan, Ren, Zijing, Yu, Jie, Li, Wen, Liu, Fangtong, Gu, Jintao, Yuan, Ye, Du, Zhimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647038/
https://www.ncbi.nlm.nih.gov/pubmed/34881240
http://dx.doi.org/10.3389/fcell.2021.731365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647038/
https://www.ncbi.nlm.nih.gov/pubmed/34881240
http://dx.doi.org/10.3389/fcell.2021.731365

Ejemplares similares